北海康成-B(01228)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01228 北海康成-B

未开盘 01-14 16:08:04

2.260

-0.050

-2.16%

最高2.390	最低2.240	成交量120.00万
今开2.330	昨收2.310	日振幅6.49%
总市值11.55亿	流通市值11.55亿	总股本5.11亿
成交额273.63万	换手率0.23%	流通股本5.11亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01228","market":"HK","secType":"STK","nameCN":"北海康成-B","latestPrice":2.26,"timestamp":1768378084942,"preClose":2.31,"halted":0,"volume":1200000,"delay":0,"changeRate":-0.02164502164502176,"floatShares":511000000,"shares":511000000,"eps":-1.1654414181449568,"marketStatus":"未开盘","change":-0.05,"latestTime":"01-14 16:08:04","open":2.33,"high":2.39,"low":2.24,"amount":2736300,"amplitude":0.064935,"askPrice":2.3,"askSize":10000,"bidPrice":2.26,"bidSize":25000,"shortable":0,"etf":0,"ttmEps":-0.35838413684744047,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768440600000},"marketStatusCode":0,"adr":0,"listingDate":1639065600000,"exchange":"SEHK","adjPreClose":2.31,"openAndCloseTimeList":[[1768354200000,1768363200000],[1768366800000,1768377600000]],"volumeRatio":0.8653014134129955,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01228","defaultTab":"news","newsList":[{"id":"2602834549","title":"北海康成-B(01228)授出合共约637.26万份购股权及637.26万份受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2602834549","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602834549?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:42","pubTimestamp":1768228951,"startTime":"0","endTime":"0","summary":"智通财经APP讯，北海康成-B(01228)公布，于2026年1月12日，公司根据首次公开发售后购股权计划向30名购股权承授人授出合共6,372,575份购股权及根据首次公开发售后受限制股份单位计划向28名受限制股份单位承授人授出合共6,372,575份受限制股份单位。授出的购股权的行使价为每股2.32港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391925.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"1132699867","title":"北海康成(1228)更新12月股份变动月报表，股本增加至约5.11亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1132699867","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132699867?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:16","pubTimestamp":1767773797,"startTime":"0","endTime":"0","summary":"北海康成制药有限公司于2026年1月7日提交截至2025年12月31日的月报表。公告显示，该公司注册股本维持在5,000,000,000股，面值每股0.00001美元，总额不变为50,000美元。本报告期内，已发行股份由上月的510,826,484股增至511,120,234股，整体增加293,750股。报告期内并无股份购回或注销活动。截至2025年12月31日，北海康成制药有限公司股本总数增至511,120,234股。公司同时确认其遵守香港联交所上市规则及相关法律规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01228"],"gpt_icon":0},{"id":"2601104074","title":"北海康成-B盘中异动 股价大跌5.08%报2.240港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601104074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601104074?lang=zh_cn&edition=full","pubTime":"2026-01-05 10:15","pubTimestamp":1767579344,"startTime":"0","endTime":"0","summary":"2026年01月05日早盘10时15分，北海康成-B股票出现波动，股价大幅下跌5.08%。截至发稿，该股报2.240港元/股，成交量14.2万股，换手率0.03%，振幅3.39%。资金方面，该股资金流入3.928万港元，流出23.953万港元。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。北海康成-B股票所在的生物技术行业中，整体涨幅为2.39%。北海康成-B公司简介：CANbridge Pharmaceuticals Inc是一家全球生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010510154497a10203&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010510154497a10203&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2601076259","title":"385只港股2025年涨幅超100% “红底股”显著增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2601076259","media":"财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601076259?lang=zh_cn&edition=full","pubTime":"2026-01-05 00:00","pubTimestamp":1767542400,"startTime":"0","endTime":"0","summary":"刚刚过去的2025年，港股市场诞生了一批涨幅超10倍的牛股，“红底股”阵营持续扩大，业内多家机构继续看好2026年港股市场。另外，股价突破100港元的“红底股”阵营持续扩大，不少新增“红底股”为去年上市的新股，也成为港股市场流动性显著提升的重要体现。截至2025年12月31日收盘，港股“红底股”数量达45只，较2025年初的22只有显著增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105095801a6f3bf3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105095801a6f3bf3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1148","00388","09961","08460","01815","09678","09988","03750","02097","01228","03690"],"gpt_icon":0},{"id":"2595876037","title":"北海康成-B盘中异动 急速下挫5.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595876037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595876037?lang=zh_cn&edition=full","pubTime":"2025-12-29 10:17","pubTimestamp":1766974671,"startTime":"0","endTime":"0","summary":"2025年12月29日早盘10时17分，北海康成-B股票出现波动，股价大幅下挫5.68%。截至发稿，该股报2.160港元/股，成交量9.7万股，换手率0.02%，振幅4.37%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。北海康成-B股票所在的生物技术行业中，整体跌幅为0.81%。北海康成-B公司简介：CANbridge Pharmaceuticals Inc是一家全球生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229101751a4840771&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229101751a4840771&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"2593411866","title":"北海康成-B12月23日获主力加仓63.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593411866","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593411866?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:15","pubTimestamp":1766477751,"startTime":"0","endTime":"0","summary":"12月23日, 北海康成-B股价涨3.70%，报收2.24元，成交金额558.3万元，换手率0.49%，振幅7.87%，量比0.96。北海康成-B今日主力资金净流入63.8万元，连续4日净流入，上一交易日主力净流入113.5万元。该股近5个交易日上涨11.82%，主力资金累计净流入240.1万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入44.2万元，其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223162046a46e0765&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223162046a46e0765&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2592221009","title":"北海康成-B盘中异动 早盘股价大跌5.34%报1.950港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592221009","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592221009?lang=zh_cn&edition=full","pubTime":"2025-12-18 10:56","pubTimestamp":1766026577,"startTime":"0","endTime":"0","summary":"2025年12月18日早盘10时56分，北海康成-B股票出现异动，股价大幅下跌5.34%。截至发稿，该股报1.950港元/股，成交量36万股，换手率0.07%，振幅3.88%。资金方面，该股资金流入12.173万港元，流出55.877万港元。北海康成-B股票所在的生物技术行业中，整体涨幅为0.52%。北海康成-B公司简介：CANbridge Pharmaceuticals Inc是一家全球生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218105618953b6928&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218105618953b6928&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"2592969294","title":"北海康成-B12月16日主力净流出31万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2592969294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592969294?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:16","pubTimestamp":1765872966,"startTime":"0","endTime":"0","summary":"12月16日, 北海康成-B股价跌3.33%，报收2.03元，成交金额182.7万元，换手率0.18%，振幅4.29%，量比0.99。北海康成-B今日主力资金净流出31万元，上一交易日主力净流出0万元。该股近5个交易日下跌6.88%，主力资金累计净流出31万元；近20日主力资金累计净流出135.0万元，其中净流出天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216162352a45192b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216162352a45192b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"2589318573","title":"北海康成-B(01228)自主研发生产的CAN 103获纳入中国第一版“商保创新药目录”","url":"https://stock-news.laohu8.com/highlight/detail?id=2589318573","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589318573?lang=zh_cn&edition=full","pubTime":"2025-12-08 18:13","pubTimestamp":1765188831,"startTime":"0","endTime":"0","summary":"智通财经APP讯，北海康成-B 公布，该集团的国内首个本土自主研发生产的酶替代疗法一类创新药CAN 103已成功纳入中国第一版“商保创新药目录”，该目录于2026年1月1日起正式实施。CAN 103于2025年5月13日获批上市，是中国首个本土自主研发生产适用于12岁及以上青少年和成人 I型和Ⅲ型戈谢病患者的长期酶替代疗法，亦为中国首个通过生物制品分段生产检查的创新生物药。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378890.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","BK4600","BK4170","BK4526","01228","BK4595"],"gpt_icon":0},{"id":"2590271363","title":"北海康成-B12月08日主力净流出147.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2590271363","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590271363?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:15","pubTimestamp":1765181745,"startTime":"0","endTime":"0","summary":"12月08日, 北海康成-B股价跌2.95%，报收2.30元，成交金额563.2万元，换手率0.48%，振幅11.81%，量比1.22。北海康成-B今日主力资金净流出147.7万元，上一交易日主力净流出0万元。该股近5个交易日上涨9.05%，主力资金累计净流出149.9万元；近20日主力资金累计净流出69.3万元，其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120816193697960bae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120816193697960bae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2589877119","title":"19种药品纳入首版商保目录，5款CAR-T疗法集体入围，影响有多大？","url":"https://stock-news.laohu8.com/highlight/detail?id=2589877119","media":"澎湃新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589877119?lang=zh_cn&edition=full","pubTime":"2025-12-07 21:37","pubTimestamp":1765114670,"startTime":"0","endTime":"0","summary":"在7日的大会现场，国家医保局相关负责人还为入选商保创新药目录的企业代表颁发了证书。根据此前公布的数据，首版商保创新药目录申报信息共有141份，涉及药品通用名141个，121个通过形式审查，实际参与商保创新药目录价格协商的药品24个。进入商保目录后，公司CAR-T疗法的对外价格还是不变的，但对于保险公司会有一个折扣价格。两款药物均出现在首版目录名单，有望造福更多AD患者。从最终的结果来看，该产品未能进入商保目录。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251207213959a439684c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251207213959a439684c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4022","06160","02161","BK4230","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","688235","ONC","LU1093756168.USD","LU1093756325.SGD","BK4585","BK4588","02196","LU0154236417.USD","NVO","01228","BK4007","BK4599","02171","BK4532"],"gpt_icon":0},{"id":"2588035157","title":"北海康成-B盘中异动 股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588035157","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588035157?lang=zh_cn&edition=full","pubTime":"2025-12-02 13:03","pubTimestamp":1764651792,"startTime":"0","endTime":"0","summary":"2025年12月02日下午盘13时03分，北海康成-B股票出现异动，股价快速上涨5.24%。截至发稿，该股报2.210港元/股，成交量143万股，换手率0.28%，振幅6.67%。北海康成-B股票所在的生物技术行业中，整体跌幅为2.06%。其相关个股中，旺山旺水-B、华康生物医学、迈博药业-B涨幅较大，振幅较大的相关个股有迈博药业-B、中生北控生物科技、维升药业-B，振幅分别为20.37%、14.21%、12.33%。北海康成-B公司简介：CANbridge Pharmaceuticals Inc是一家全球生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202130312952606dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202130312952606dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2588099797","title":"智通港股投资日志|12月1日","url":"https://stock-news.laohu8.com/highlight/detail?id=2588099797","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588099797?lang=zh_cn&edition=full","pubTime":"2025-12-01 00:00","pubTimestamp":1764518402,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，2025年12月1日，港股上市公司投资日志如下：    类别 公司  新股活动卓越睿新(招股中)纳芯微(招股中)天域半导体(招股中)遇见小面(招股中)乐摩科技(定价日) 业绩公布日港通控股 股东大会召开日瀛晟科学HSSP INTL辽港股份细叶榕科技城市酷选中国环境资源北海康成-B高鑫零售PALADIN铁建装备 停复牌亨得利（复牌） 分红派息雅各臣科研制药（除净日）敏华控股（除净","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1375700.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2586999654","title":"北海康成-B11月24日主力净流入60.9万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2586999654","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586999654?lang=zh_cn&edition=full","pubTime":"2025-11-24 16:15","pubTimestamp":1763972145,"startTime":"0","endTime":"0","summary":"11月24日, 北海康成-B股价涨1.56%，报收1.95元，成交金额166.9万元，换手率0.17%，振幅6.25%，量比0.47。北海康成-B今日主力资金净流入60.9万元，上一交易日主力净流出0万元。该股近5个交易日下跌6.25%，主力资金累计净流入67.4万元；近20日主力资金累计净流出159.2万元，其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124162024a70dd89d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124162024a70dd89d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2585533111","title":"北海康成-B盘中异动 早盘急速下跌5.94%报1.900港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585533111","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585533111?lang=zh_cn&edition=full","pubTime":"2025-11-21 09:33","pubTimestamp":1763688814,"startTime":"0","endTime":"0","summary":"2025年11月21日早盘09时33分，北海康成-B股票出现异动，股价大幅跳水5.94%。截至发稿，该股报1.900港元/股，成交量1.6万股，换手率0.00%，振幅4.46%。资金方面，该股资金流入0港元，流出2.95万港元。北海康成-B股票所在的生物技术行业中，整体跌幅为2.11%。北海康成-B公司简介：CANbridge Pharmaceuticals Inc是一家全球生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511210933349511975a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511210933349511975a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"1108622160","title":"CANbridge(1228)将于12月4日召开股东特别大会 审议增发与扩大发行授权","url":"https://stock-news.laohu8.com/highlight/detail?id=1108622160","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108622160?lang=zh_cn&edition=full","pubTime":"2025-11-19 16:46","pubTimestamp":1763541971,"startTime":"0","endTime":"0","summary":"CANbridge(1228)将于2025年12月4日上午9时以虚拟方式召开股东特别大会，拟审议并表决多项普通决议案。\n主要议程包括撤销并重授董事配发、发行及买卖公司未发行股份的一般授权，覆盖已发行股份总数的20%，并拟在此基础上进一步扩大授权上限10%。据公告，为便于股东参与，公司将通过线上平台(http://meetings.computershare.com/CANPEGM2025)开放投票及提问。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01228"],"gpt_icon":0},{"id":"2584435899","title":"北海康成-B盘中异动 早盘股价大跌5.03%报1.890港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584435899","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584435899?lang=zh_cn&edition=full","pubTime":"2025-11-19 10:20","pubTimestamp":1763518855,"startTime":"0","endTime":"0","summary":"2025年11月19日早盘10时20分，北海康成-B股票出现波动，股价快速跳水5.03%。截至发稿，该股报1.890港元/股，成交量9.7万股，换手率0.02%，振幅5.03%。资金方面，该股资金流入2.126万港元，流出16.199万港元。北海康成-B股票所在的生物技术行业中，整体跌幅为1.41%。北海康成-B公司简介：CANbridge Pharmaceuticals Inc是一家全球生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111910205597726006&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111910205597726006&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2584023605","title":"决胜港股升浪·牛启东方2026——第十届智通财经资本市场年会邀您共赴资本盛宴","url":"https://stock-news.laohu8.com/highlight/detail?id=2584023605","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584023605?lang=zh_cn&edition=full","pubTime":"2025-11-18 08:53","pubTimestamp":1763427196,"startTime":"0","endTime":"0","summary":"由港美股第一资讯平台智通财经与中资海外私募基金一站式服务平台新智基金网联合主办，“冬日暖阳” 独家承办，S&P Global Market Intelligence、CITIZEN支持的“第十届智通财经资本市场年会”将于2025年12月3-5日联动深圳与香港两地举行。本届年会以\"决胜港股升浪·牛启东方2026\"为主题，设置六大核心议程，汇聚全球资本力量，共探宽松周期尾声的领涨赛道与中国资产长期增长潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1370226.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00302","03658","02177","02509","02511","00305","01164","00363","01333","02256","00003","09911","02488","00604","00699","09959","01167","02561","02268","02453","06682","09878","00855","09996","02627","00290","00826","02096","06608","00382","02171","00867","02279","06660","01228","00552","00196","02142","09678","01318","06996","02105","02167","06609","00861","02587","02431","02670","02157","02420"],"gpt_icon":0},{"id":"2584610154","title":"北海康成-B(01228.HK)盘中涨近18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584610154","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584610154?lang=zh_cn&edition=full","pubTime":"2025-11-17 15:46","pubTimestamp":1763365596,"startTime":"0","endTime":"0","summary":"每经AI快讯，北海康成-B(01228.HK)盘中涨近18%，截至发稿，涨11.76%，报2.09港元，成交额1021.88万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511173566228338.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511173566228338.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2584610820","title":"港股异动 | 北海康成-B(01228)盘中涨近18% 旗下三款罕见病产品均纳入2026年度北京普惠健康保","url":"https://stock-news.laohu8.com/highlight/detail?id=2584610820","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584610820?lang=zh_cn&edition=full","pubTime":"2025-11-17 15:38","pubTimestamp":1763365127,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，北海康成-B(01228)盘中涨近18%，截至发稿，涨11.76%，报2.09港元，成交额1021.88万港元。消息面上，2026年度“北京普惠健康保”保障详情已于近期公布，北海康成三款罕见病产品均已纳入，其中戈芮宁首次亮相“惠民保”。据悉，戈芮宁于今年5月13日获批上市。7月2日，戈芮宁在上海交通大学医学院附属新华医院开出首方，标志着该药物正式进入临床应用，未来将大大提升国内患者用药可及。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369932.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01228","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ssitimber.com.hk","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.0762},{"period":"3month","weight":-0.0131},{"period":"6month","weight":2.0541},{"period":"1year","weight":18.4828},{"period":"ytd","weight":-0.1172}],"compareEarnings":[{"period":"1week","weight":0.0204},{"period":"1month","weight":0.0535},{"period":"3month","weight":0.0429},{"period":"6month","weight":0.0876},{"period":"1year","weight":0.4048},{"period":"ytd","weight":0.0534}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"CANbridge Pharmaceuticals Inc是一家全球生物制药公司。该公司专注于罕见病转化疗法的研究、开发和商业化。该公司拥有一个药物组合，其中包括三种获批药物和八种资产的管线，针对尚未满足需求的罕见病适应症。这些包括亨特综合征和其他溶酶体贮积症、阵发性睡眠性血红蛋白尿和其他补体介导的疾病、血友病A、代谢性疾病、罕见胆汁淤积性肝病和神经肌肉疾病。其管线包括Hunterase、Livmarli、CAN106和CAN103。Hunterase是一种酶替代疗法，用于治疗II型粘多糖贮积症（MPS II），也称为亨特综合征。Livmarli是一种口服、吸收率极低、可逆性的回肠胆汁酸转运蛋白抑制剂，正在开发中，用于治疗罕见的胆汁淤积性肝病，包括Alagille综合征和进行性家族性肝内胆汁淤积症。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.16681},{"month":2,"riseRate":0.25,"avgChangeRate":0.001379},{"month":3,"riseRate":0.25,"avgChangeRate":-0.105397},{"month":4,"riseRate":0.25,"avgChangeRate":-0.006446},{"month":5,"riseRate":0,"avgChangeRate":-0.117685},{"month":6,"riseRate":0.25,"avgChangeRate":0.256405},{"month":7,"riseRate":0.5,"avgChangeRate":0.547002},{"month":8,"riseRate":0.25,"avgChangeRate":0.239858},{"month":9,"riseRate":0.75,"avgChangeRate":0.161514},{"month":10,"riseRate":0,"avgChangeRate":-0.161874},{"month":11,"riseRate":0.25,"avgChangeRate":-0.205763},{"month":12,"riseRate":0.5,"avgChangeRate":0.059277}],"exchange":"SEHK","name":"北海康成-B","nameEN":"CANBRIDGE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"北海康成-B(01228)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供北海康成-B(01228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"北海康成-B,01228,北海康成-B股票,北海康成-B股票老虎,北海康成-B股票老虎国际,北海康成-B行情,北海康成-B股票行情,北海康成-B股价,北海康成-B股市,北海康成-B股票价格,北海康成-B股票交易,北海康成-B股票购买,北海康成-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"北海康成-B(01228)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供北海康成-B(01228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}